The disclosure relates to compositions, methods, and kits that can be used to assess neurodegeneration associated diseases and conditions in a subject by detecting the Ievel of TAR DNA-binding protein 43 (TDP-43) in platelets. The compositions, methods, and kits are suitable for neurodegeneration associated disease diagnosis, prognosis and treatment evaluation.
BIOMARKER FOR EARLY NEURODEGENERATION DETECTION